Literature DB >> 34306404

The effects of solution-focused nursing on leukemia chemotherapy patients' moods, cancer-related fatigue, coping styles, self-efficacy, and quality of life.

Jing Wang1, Yun Yin1, Yanping Li1, Xuli Yue1, Xiangming Qi1, Min'na Sun1.   

Abstract

OBJECTIVE: To explore the effects of solution-focused nursing on leukemia chemotherapy patients' moods, cancer-related fatigue, coping styles, self-efficacy, and quality of life.
METHODS: A total of 103 patients who underwent leukemia chemotherapy in our hospital were analyzed retrospectively and were divided into two groups based on the intervention method. Group A underwent routine nursing intervention, and group B underwent solution-focused nursing. The Hamilton Anxiety Rating Scale (HAMA) scores, the Montgomery-Asberg Depression Rating Scale (MADRS) scores, the Trait Coping Style Questionnaire (TCSQ) scores, the cancer-related fatigue self-rating scores, the General Self-Efficacy Scale (GSES) scores, and the Spitzer Quality of Life Index scores were compared between the two groups.
RESULTS: Compared with group A, group B had lower HAMA scores, lower MADRS scores, lower cognitive, behavioral, perception, and emotional scores, and higher self-efficacy scores (P<0.05). Group B had higher activity scores, and better psychological statuses, support from family and friends, health perception, and outlook on life than group A after the intervention (P<0.05).
CONCLUSION: Solution-focused nursing can alleviate leukemia chemotherapy patients' negative emotions and cancer-related fatigue, improve their coping styles, and increase their self-efficacy and quality of life. AJTR
Copyright © 2021.

Entities:  

Keywords:  Leukemia; cancer-induced fatigue; coping style; emotion; quality of life; self-efficacy; solution-focused nursing

Year:  2021        PMID: 34306404      PMCID: PMC8290694     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.

Authors:  Fevzi Yalniz; Iman Abou Dalle; Hagop Kantarjian; Gautam Borthakur; Tapan Kadia; Keyur Patel; Sanam Loghavi; Guillermo Garcia-Manero; Koji Sasaki; Naval Daver; Courtney DiNardo; Naveen Pemmaraju; Nicholas J Short; Musa Yilmaz; Prithviraj Bose; Kiran Naqvi; Sherry Pierce; Graciela M Nogueras González; Marina Konopleva; Michael Andreeff; Jorge Cortes; Farhad Ravandi
Journal:  Am J Hematol       Date:  2019-06-24       Impact factor: 10.047

2.  Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.

Authors:  Jason Chen; Dat Ngo; Joseph Rosenthal
Journal:  J Oncol Pharm Pract       Date:  2018-12-11       Impact factor: 1.809

Review 3.  Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Authors:  Per Ljungman; Rafael de la Camara; Christine Robin; Roberto Crocchiolo; Hermann Einsele; Joshua A Hill; Petr Hubacek; David Navarro; Catherine Cordonnier; Katherine N Ward
Journal:  Lancet Infect Dis       Date:  2019-05-29       Impact factor: 25.071

4.  Higher incidence of syndrome of inappropriate antidiuretic hormone secretion during induction chemotherapy of acute lymphoblastic leukemia in indian children.

Authors:  Shwetha Seetharam; Priyakumari Thankamony; Kaduveettil Gopinathan Gopakumar; K M Jagathnath Krishna
Journal:  Indian J Cancer       Date:  2019 Oct-Dec       Impact factor: 1.224

5.  Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials.

Authors:  Jorge E Cortes; Hervé Dombret; Akil Merchant; Tetsuzo Tauchi; Christine G DiRienzo; Barbara Sleight; Xiaoxi Zhang; Eric P Leip; Naveed Shaik; Timothy Bell; Geoffrey Chan; Mikkael A Sekeres
Journal:  Future Oncol       Date:  2019-09-13       Impact factor: 3.404

6.  Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Authors:  Rebeca Rodríguez-Veiga; Pau Montesinos; Blanca Boluda; Ignacio Lorenzo; David Martínez-Cuadrón; Miguel Salavert; Javier Pemán; Pilar Calvillo; Isabel Cano; Evelyn Acuña; Ana Villalba; José Luis Piñana; Jaime Sanz; Pilar Solves; Leonor Senent; Ana Vicente; Amparo Sempere; José Cervera; Eva Barragán; Isidro Jarque; Antonio Torres; Miguel A Sanz; Guillermo F Sanz
Journal:  Ann Hematol       Date:  2019-06-25       Impact factor: 3.673

7.  Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia.

Authors:  Sarah Elitzur; Nira Arad-Cohen; Shlomit Barzilai-Birenboim; Miriam Ben-Harush; Bella Bielorai; Ronit Elhasid; Tamar Feuerstein; Gil Gilad; Alexander Gural; Mira Kharit; Naomi Litichever; Ronit Nirel; Sigal Weinreb; Ofir Wolach; Amos Toren; Shai Izraeli; Elad Jacoby
Journal:  Pediatr Blood Cancer       Date:  2019-07-02       Impact factor: 3.167

8.  Glasdegib for the treatment of adult patients with newly diagnosed acute myeloid leukemia or high-grade myelodysplastic syndrome who are elderly or otherwise unfit for standard induction chemotherapy.

Authors:  S R Goldsmith; A R Lovell; M A Schroeder
Journal:  Drugs Today (Barc)       Date:  2019-09       Impact factor: 2.245

9.  Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.

Authors:  Nicole A McNeer; John Philip; Heather Geiger; Rhonda E Ries; Vincent-Philippe Lavallée; Michael Walsh; Minita Shah; Kanika Arora; Anne-Katrin Emde; Nicolas Robine; Todd A Alonzo; E Anders Kolb; Alan S Gamis; Malcolm Smith; Daniela Se Gerhard; Jaime Guidry-Auvil; Soheil Meshinchi; Alex Kentsis
Journal:  Leukemia       Date:  2019-02-13       Impact factor: 11.528

Review 10.  How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia.

Authors:  Brian A Jonas; Daniel A Pollyea
Journal:  Leukemia       Date:  2019-10-18       Impact factor: 11.528

View more
  2 in total

1.  Clinical efficacy and safety of comprehensive nursing intervention in acute leukemia patients with myelosuppression after chemotherapy.

Authors:  Xiaoqian Han; Lihua Tian
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Application of Narrative Nursing Combined With Focused Solution Model to Anxiety and Depression in Patients With Lung Tumor During Perioperative Period.

Authors:  Jing Feng; Ling Ge; Fengxia Jin; Li Jiang
Journal:  Front Surg       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.